This trial is testing a device that could help screen, detect, and monitor symptoms linked to respiratory diseases like COVID-19. The device measures breathing, body temperature, heart rate, and tissue oxygenation.
1 Primary · 2 Secondary · Reporting Duration: End of study
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Fitbit · No Placebo Group · N/A
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:District of Columbia | 40.0% |
Florida | 40.0% |
Texas | 20.0% |
65+ | 50.0% |
18 - 65 | 50.0% |
Met criteria | 50.0% |
Did not meet criteria | 50.0% |
National Institutes of Health Clinical Center | 100.0% |